{
    "clinical_study": {
        "@rank": "78795", 
        "arm_group": [
            {
                "arm_group_label": "UofL Subjects", 
                "description": "Subjects undergoing Specimen Collection at University Kidney Center, University of Louisville, Louisville, KY"
            }, 
            {
                "arm_group_label": "Duke Subjects", 
                "description": "Subjects undergoing Specimen Collection at Duke University, Durham, NC"
            }, 
            {
                "arm_group_label": "WNERTA Subjects", 
                "description": "Subject undergoing Specimen Collection at Western New England Renal and Transplant Associates, Springfield, MA"
            }
        ], 
        "biospec_descr": {
            "textblock": "Blood, serum will be extracted and frozen for further analysis. Serum will be retained for\n      up to 60 days."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to prospectively collect data on doses of Erythropoietic\n      Stimulating Agents and Intravenous Iron, and the markers of erythropoietic activity and iron\n      status. These data will be used to derive mathematical models which will subsequently guide\n      dosing of both agents, such that a desired therapeutic outcome is achieved in every patient,\n      while minimizing patient exposure to both agents."
        }, 
        "brief_title": "Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Anemia of End Stage Renal Disease", 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Kidney Diseases", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Data will be collected from 120 subjects undergoing hemodialysis treatment at 3 clinical\n      sites across United States (40 per site).5.5 mL blood specimen will be drawn during midweek\n      treatment (Wed/Thu) to measure:\n\n      Hemoglobin Concentration Hematocrit Red Blood Cell Count Platelet Count Reticulocyte\n      Percentage Reticulocyte Hemoglobin Mean Cellular Hemoglobin Mean Cellular Hemoglobin\n      Concentration Mean Cell Volume Red Cell Volume Distribution Width Mean Platelet Volume Serum\n      Iron Serum Ferritin Transferrin Saturation Hepcidin Soluble Transferrin Receptor\n\n      Weekly ESA and Iron dose delivered will also be recorded.\n\n      From these data:\n\n        1. a mathematical model will be established to find biomarkers most descriptive with\n           respect to erythropoiesis-iron synergy,\n\n        2. a mathematical model will be established to correlate iron dose with iron markers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  receiving or expected to receive ESA\n\n        Exclusion Criteria:\n\n          -  life expectancy less than 12 months\n\n          -  frequent (once or more per month w/in last 6 months) uncontrolled blood loss\n\n          -  frequent (once or more per month w/in last 6 months) hospitalization\n\n          -  frequent (once or more per month w/in last 6 months) access complications"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "End Stage Renal Disease Patients undergoing hemodialysis treatments at:\n\n          1. University Kidney Center, Louisville, KY\n\n          2. Duke University, Durham, NC\n\n          3. WNERTA, Springfield, MA"
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01719146", 
            "org_study_id": "R01 DK093832-01A1", 
            "secondary_id": "R01DK093832"
        }, 
        "intervention": {
            "arm_group_label": [
                "UofL Subjects", 
                "Duke Subjects", 
                "WNERTA Subjects"
            ], 
            "description": "At the beginning of each midweek hemodialysis session, a blood specimen (4 mL) will be drawn from the study subject. Out of this specimen a 1 mL serum sample will be frozen and stored. A 3 mL blood sample will be shipped overnight to WNERTA for laboratory testing.", 
            "intervention_name": "Specimen collection", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Epoetin Alfa", 
                "Hematinics"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Anemia", 
            "Chronic Kidney Disease", 
            "Erythropoiesis Stimulating Agents", 
            "Erythropoietin", 
            "Iron", 
            "Iron Deficiency"
        ], 
        "lastchanged_date": "January 25, 2013", 
        "location": [
            {
                "contact": {
                    "email": "amdalt01@exchange.louisville.edu", 
                    "last_name": "Amanda Moore", 
                    "phone": "502-852-2290"
                }, 
                "contact_backup": {
                    "email": "rnande03@louisville.edu", 
                    "last_name": "Rachael Anderson", 
                    "phone": "502-852-2290"
                }, 
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40202"
                    }, 
                    "name": "University of Louisville, University Kidney Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Adam E Gaweda, Ph.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "George R Aronoff, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Michael.Germain@baystatehealth.org", 
                    "last_name": "Michael J Germain, M.D.", 
                    "phone": "413-794-2604"
                }, 
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01107"
                    }, 
                    "name": "Western New England Renal and Transplant Associates"
                }, 
                "investigator": {
                    "last_name": "Michael J Germain, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "patrick.pun@duke.edu", 
                    "last_name": "Patrick H Pun, MD", 
                    "phone": "919-660-6865"
                }, 
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke University"
                }, 
                "investigator": {
                    "last_name": "Patrick Pun, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Computational Approach to Personalized Anemia Management", 
        "other_outcome": [
            {
                "measure": "Transferrin Saturation (%)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Serum Ferritin (ng/mL)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "University of Louisville", 
            "last_name": "Adam E Gaweda, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hemoglobin Concentration (g/dL)", 
            "safety_issue": "No", 
            "time_frame": "52 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01719146"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Reticulocyte Percentage (%)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Reticulocyte Hemoglobin Equivalent, RetHe (pg)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }
        ], 
        "source": "University of Louisville", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Louisville", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}